Micro MD has advised us that Hydrocodone Combination Products (HCP’s) will be classified as Schedule II drugs as of October 16, 2014. The notification from Henry Schein is below:
DEA Final Rule classifies Hydrocodone Combination Products (HCPs) as Schedule II as of October 6, 2014
Dear Valued MicroMD PM + EMR Clients:
On October 6, 2014, a U. S. Drug Enforcement Administration (DEA) Final Rule officially moves hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II, as recommended by the Assistant Secretary for Health of the U.S. Department of Health and Human Services (HHS) and as supported by the DEA’s own evaluation of relevant data. The Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs.
MicroMD EMR Medication Info Updates: While there will be no change to how you currently prescribe scheduled drugs in MicroMD EMR, we’re awaiting an update of our First Databank (FDB) medication info so that the impacted drugs will indicate the current schedule classification in your software. FDB confirmed that they’ll make the updated data 外汇交易平台 available this week. Once we receive the updated data, we’ll automatically update the information on the following Sunday night so that it’s current in the software the following Monday. We expect the changes to be available in MicroMD EMR on either Monday, October 6 or Monday, October 13, depending on the receipt of the modified database from FDB.
Future Plans for Electronic Prescribing of Controlled Substances (EPCS): As the State of NY is mandating that all prescriptions be ePrescribed – including controlled substances – as of March 27, 2015. MicroMD is currently planning to launch an EPCS solution available from within MicroMD before the deadline.
If you’re not currently using MicroMD EMR and want to ensure you’ll be working with a solution offering integrated EPCS, please contact us at
If you have any questions regarding the schedule change, .
As always, the OMS web page can be found .
We know you have a choice and we thank you for partnering with OMS!